Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-914-1 | CAS number: 1066-40-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (Bacterial reverse mutation assay / Ames test): negative with and without metabolic activation in Salmonella typhimurium strains TA 98, TA 100, TA 1535 or TA 1537, or E.coli WP2 uvrA (OECD TG 471) (Dow Corning Corporation, 1995).
Cytogenicity in mammalian cells: negative in Chinese hamster lung
fibroblasts (Japanese guideline similar to OECD TG 473) (Hita
laboratories, 1994).
Mutagenicity in mammalian cells: negative in L5178Y mouse lymphoma
cells (similar to OECD TG 476, 1997) (Litton Bionetics, 1978).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Chromosome aberration assay in rat (ip administration): negative (similar to OECD 475) (Bioassay Systems Corporation, 1982).
Rodent dominant lethal assay in rat (oral gavage): negative (OECD
426 (1981), similar to OECD 478) (Dow Corning Corporation, 1983).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Trimethylsilanol has been tested for mutagenicity to bacteria, in a study which was conducted according to OECD TG 471, compliant with GLP (Dow Corning Corporation, 1995)). No evidence of a test-substance related increase in the number of revertants was observed with or without metabolic activation in Salmonella typhimurium strains TA 98, TA 100, TA 1535 or TA 1537, or E. coli WP2 uvrA, in the initial or the repeat experiments using the plate incorporation method up to limit concentrations. Appropriate positive and solvent controls were included and gave expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test.
The key study for mutagenicity to bacteria is supported by three older studies (Mitsubishi (undated); Litton Bionetics, 1978; Wacker, 1986). The results of all the studies are in agreement.
Trimethylsilanol has been tested for cytogenicity to mammalian cells in a study conducted according to a Japanese test guideline equivalent to OECD 473 and in compliance with GLP (Hita laboratories, 1994). No test-substance related increase in the number of cells with aberrations was observed when Chinese hamster lung fibroblasts were treated with 225, 450 and 900 μg/ml of test substance in the presence and absence of metabolic activation. No cytotoxicity was observed up to the limit concentration of 900 μg/ml (10mM). It was concluded that the test substance was negative for cytogenicity under the conditions of the test.
The key study for in vitro cytogenicity is supported by three older studies (Mitsubishi (undated); Litton Bionetics, 1978; Litton Bionetics, 1979). The first of these reported chromosome aberrations in Chinese hamster lung fibroblasts, the two Litton Bionetics studies used mouse lymphoma L5178Y cells. The results of all the studies were in agreement.
Trimethylsilanol has been tested for mutagenicity to mouse lymphoma cells up to cytotoxic concentrations according to a protocol that is similar to OECD 476 (1997) (Litton Bionetics, 1978). No increase in mutant frequency was observed in either the absence or presence of exogenous metabolic activation. Appropriate controls were included and gave expected results. It is concluded that the test substance is not mutagenic in mouse lymphoma L5178Y cells under the conditions of the test.
Litton Bionetics (1978) reported a test substance induced increase in sister chromatid exchanges per cell in L5178Y cells. As a clear dose response was not reported and this method is no longer used in the evaluation of mutagenicity, and in addition reliable data are available from in vitro and in vivo chromosome aberration studies, this result is ignored.
The same study also evaluate DNA damage using an elution technique: no evidence was found for test substance DNA damage in L5178Y cells.
The results obtained from the in vitro studies were confirmed when the substance was tested in vivo. In the key in vivo chromosome aberration assay, trimethylsilanol was tested in conducted according to a protocol that is similar to OECD 475 (Bioassay Systems Corporation, 1982). The test substance did not cause a statistically significant, dose related increase in chromosome breaks or aberrations when administered by intraperitoneal injection to Sprague Dawley rats up to the maximum tolerated dose. It is concluded that the test substance is not clastogenic in rat bone marrow cells under the conditions of the test.
A second in vivo chromosome aberration study is available (Litton Bionetics, 1984). The results of the key and supporting in vivo chromosome aberration studies are in agreement.
Data are available for mutagenicity to germ cells from a rodent dominant
lethal assay in which trimethylsilanol was tested according to OECD 426
(1981), equivalent to OECD 478 (Dow Corning Corporation, 1983). The test
substance was administered to male rats at three dose levels, for five
days per week over eight week. No evidence of induction of chromosomal
damage in germinal tissue was obtained from the study; there was no
substance related effect on fertility index, per-implantation loss or
resorption rate. A clear dominant lethal syndrome was evident in the
positive control group. Although the test material was administered at a
high enough level to induce transient sedation without toxicity, no
reduction in male fertility or increase in dominant lethality was
obtained. It is concluded that the test substance is negative for
genetic toxicity to germ cells under the conditions of the test.
Justification for classification or non-classification
Based on the available in vitro and in vivo data, trimethylsilanol does not require classification for mutagenicity according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.